Activation of monocytes via their Fc alpha R increases procoagulant activity

I Keidan1, J Laufer, R Shor

  • 1Samuel Jared Kushnick Pediatric Immunology Laboratory, Israel.

Insights

Activation of the Fc alpha receptor on monocytes by immunoglobulin A (IgA) immune complexes increases their procoagulant activity (PCA), contributing to kidney disease progression.

Area of Science:

  • Immunology
  • Nephrology
  • Pathophysiology

Background:

  • Macrophages accumulate in kidneys during glomerulonephritis, such as IgA nephropathy.
  • Increased kidney procoagulant activity (PCA) is linked to disease progression.

Purpose of the Study:

  • To investigate the effect of activating the monocyte Fc alpha receptor (FcαR) on PCA.
  • To understand the role of FcαR-mediated IgA interactions in kidney disease.

Main Methods:

  • Monocytes were incubated with IgA immune complexes or aggregated IgA.
  • PCA was measured following FcαR activation.
  • Inhibitory effects of galactose and corticosteroids were assessed.

Main Results:

  • IgA-mediated FcαR activation dose-dependently increased monocyte PCA.
  • Maximal PCA increase occurred after 6 hours of incubation.
  • Galactose inhibited FcαR-mediated PCA, while corticosteroids also reduced it.

Conclusions:

  • FcαR activation by IgA contributes to monocyte PCA.
  • These findings are relevant to the immunopathogenesis of IgA nephropathy and other IgA-mediated kidney diseases.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...